Pacheco Barcia, Vilma Emilia

Publications

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

  • Lara-Morga, C.
  • Palka-Kotlowska, M.
  • Custodio-Cabello, S.
  • Pacheco-Barcia, V.
  • Cabezón-Gutiérrez, L.

Exploration of Targeted Anti-tumor Therapy (p. 307-315) - 2023

Editor: Open Exploration Publishing Inc

10.37349/etat.2023.00136 View at source

  • ISSN/ISBN 2692-3114

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

  • Pacheco-Barcia, V.
  • Mondéjar Solís, R.
  • France, T.
  • Asselah, J.
  • Donnay, O.
  • Zogopoulos, G.
  • Bouganim, N.
  • Guo, K.
  • Rogado, J.
  • Martin, E.
  • Alcindor, T.
  • Colomer, R.
... View more Collapse

Pancreatology (p. 254-264) - 1/3/2020

Editor: Elsevier B.V.

10.1016/j.pan.2019.12.010 View at source

  • ISSN 14243903
  • ISSN/ISBN 1424-3911

A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer

  • Pacheco-Barcia, V.
  • Mondéjar Solís, R.
  • France, T.
  • Asselah, J.
  • Donnay, O.
  • Zogopoulos, G.
  • Bouganim, N.
  • Guo, K.
  • Rogado, J.
  • Martin, E.
  • Alcindor, T.
  • Colomer, R.
... View more Collapse

Pancreas (p. E45-E47) - 1/5/2019

Editor: Lippincott Williams and Wilkins

10.1097/mpa.0000000000001294 View at source

  • ISSN 08853177
  • ISSN/ISBN 1536-4828

This researcher has no books.

This researcher has no book chapters.

This researcher has no conferences.

This researcher has no working papers.

This researcher has no technical reports.

This researcher has no research projects.

This researcher has no supervised thesis.

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM